About Rapross Pharmaceuticals Private Limited
Data last updated: 18 December 2025
Rapross Pharmaceuticals Private Limited is a private limited company based in Delhi, Delhi, India. It specialises in api manufacturers, a part of the broader pharmaceuticals sector. Incorporated on 22 March 1995, the company has been in operation for over 31 years.
Registered with ROC Delhi under CIN U74899DL1995PTC066606.
Capital: an authorised share capital of ₹1 Cr and a paid-up capital of ₹25 Lakh. It is led by directors including Nimit Bansal and Sharad Verma.
Last AGM: 28 September 2024. Financial statements filed for year ended 31 March 2024. Office: Ii Floor Garg Plaza 5 Community Centre Sector – 8 Rohini, Delhi, Delhi, India – 110085.
As per the financials filed for FY 2023, the company reported a revenue of ₹29.39 Cr, a growth of 3% compared to the previous year.
The company has a workforce of approximately 326 employees as per the latest available data.
As per MCA filings, the company has satisfied charges of ₹5 Cr on record.
The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website raprosspharma.com.
-
EmailLocked
-
TelephoneLocked
-
Website
-
Social Media
-
Registered AddressIi Floor Garg Plaza 5 Community Centre Sector – 8 Rohini, Delhi, Delhi, India – 110085
-
IndustryPharma, API Manufacturers
- Historical Financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Litigation, compliance and MCA filings
- PDF report delivered after checkout
Business Activity of Rapross Pharmaceuticals Private Limited
Rapross Pharmaceuticals Private Limited is engaged in the principal business activity of manufacturing, with detailed activities including chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products | Locked |
Business activity turnover details for Rapross Pharmaceuticals Private Limited
Turnover contribution percentages and historical activity changes require an active report plan.
- Turnover contribution
- Historical classifications
- Filing-level activity changes
Verified entity values are shown only after access is granted.
Auditor Details of Rapross Pharmaceuticals Private Limited
Rapross Pharmaceuticals Private Limited is audited by ANM & Associates for the financial year 2023. The auditor plays a crucial role in ensuring financial transparency and compliance with accounting standards.
| Name | Status | Appointment Date | Cessation Date |
|---|---|---|---|
| ANM & Associates | Locked | Locked | Locked |
Complete auditor history for Rapross Pharmaceuticals Private Limited
Appointment status, appointment dates, cessation dates, and historical auditor changes require an active report plan.
- Appointment status
- Appointment dates
- Cessation dates
- Auditor changes
Verified entity values are shown only after access is granted.
Board of Directors of Rapross Pharmaceuticals Private Limited
Rapross Pharmaceuticals Private Limited is currently managed by 5 directors, with 4 former directors having served the organization. The current Directors play a crucial role in shaping the company's strategic direction and governance.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Nimit Bansal | Additional Director | 01 Sep 2023 | 2 Years 11 Months | Current |
| Sharad Verma | Additional Director | 01 Sep 2023 | 2 Years 11 Months | Current |
| Parveen Kumar Bansal | Director | 04 Apr 1995 | 31 Years 4 Months | Current |
| Ranjan Verma | Director | 04 Apr 1995 | 31 Years 4 Months | Current |
| Shailendra Singh | Additional Director | 11 Aug 2025 | 1 Years 0 Months | Current |
Financials of Rapross Pharmaceuticals Private Limited FY 2024 filings available
Rapross Pharmaceuticals Private Limited reported revenue of ₹29.39 Cr (up 3.00% YoY) for FY 2023.
Ten-year financial statements for Rapross Pharmaceuticals Private Limited
Historical statement values and trend charts require an active report plan.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Ownership and Shareholding of Rapross Pharmaceuticals Private Limited
Shareholding and ownership data for Rapross Pharmaceuticals Private Limited
Promoter, institutional, public, and beneficial ownership values require an active report plan.
- Ownership categories
- Historical changes
- Group structure
- FII and DII holdings
Verified entity values are shown only after access is granted.
Charges & Borrowings of Rapross Pharmaceuticals Private Limited
| Date | Lender | Amount | Status |
|---|---|---|---|
| 04 Jul 2022 | Axis Bank Limited | ₹5 Cr | Satisfied |
Total charge records: 1 View all charges
Employees and EPFO Compliance at Rapross Pharmaceuticals Private Limited
Rapross Pharmaceuticals Private Limited has a workforce of 326 employees as of Mar 20, 2025.
Employee and EPFO history for Rapross Pharmaceuticals Private Limited
Monthly headcount, contribution history, establishment records, and filing compliance require an active report plan.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
GST Compliance of Rapross Pharmaceuticals Private Limited
GST registrations and filing compliance for Rapross Pharmaceuticals Private Limited
State-wise registrations, return filing status, HSN and SAC details, and jurisdiction records require an active report plan.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
Credit Ratings, Litigation & Regulatory Alerts for Rapross Pharmaceuticals Private Limited
Credit ratings, litigation, and regulatory alerts for Rapross Pharmaceuticals Private Limited
Agency ratings, court records, regulatory events, and entity-specific compliance alerts require an active report plan.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Rapross Pharmaceuticals Private Limited
MSME payment history for Rapross Pharmaceuticals Private Limited
Amounts outstanding to micro and small suppliers, delay reasons, and MSME-1 filing history require an active report plan.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Rapross Pharmaceuticals Private Limited
Corporate group structure for Rapross Pharmaceuticals Private Limited
Parent, subsidiary, associate, joint venture, and ownership records require an active report plan.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Rapross Pharmaceuticals Private Limited
MCA filings and documents for Rapross Pharmaceuticals Private Limited
Official forms, annual returns, financial statements, charge filings, and document dates require an active report plan.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Recent Activity on Rapross Pharmaceuticals Private Limited
Frequently Asked Questions about Rapross Pharmaceuticals Private Limited
Rapross Pharmaceuticals Private Limited is an active private limited company in the pharma sector based in Delhi, Delhi, India. It was incorporated on 22 March 1995 (31+ years old) and is registered under CIN U74899DL1995PTC066606. The company has 326 employees.
Rapross Pharmaceuticals Private Limited reported revenue of ₹29.39 Cr for FY 2023 (up 3.00% YoY).
The current directors of Rapross Pharmaceuticals Private Limited are:
- Nimit Bansal - Additional Director
- Sharad Verma - Additional Director
- Parveen Kumar Bansal - Director
- Ranjan Verma - Director
- Shailendra Singh - Additional Director
The primary industry of Rapross Pharmaceuticals Private Limited is pharma. The company specifically operates in api manufacturers. The company is currently active in this sector.
Rapross Pharmaceuticals Private Limited can be reached at the registered office: Ii Floor Garg Plaza 5 Community Centre Sector – 8 Rohini, Delhi, Delhi, India – 110085, or through the website raprosspharma.com.
The authorised capital is ₹1 Cr, and the paid-up capital is ₹25 Lakh.